A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

Clinical trial NCT06606340 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06606340
Sponsor: Sarepta Therapeutics, Inc.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Duchenne Muscular Dystrophy

Start date: 2019-01-07
Primary completion: 2033-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.